The Europe protein expression market is expected to progress at a CAGR of 10.57% during the forecast period, 2019-2028. The utilization of protein expression for various disease therapies has increased. The region has a high prevalence rate of cancer, with a substantial number of cases getting registered every year. The most prevalent cancers are female breast cancer followed by prostate cancer, lung cancer, and colorectal cancer. Along with these, the presence of key players contributes to boosting the overall growth of the market.
EUROPE PROTEIN EXPRESSION MARKET FORECAST 2019-2028
Europe Protein Expression Market by Product Type (Reagents, Expression Vectors, Competent Cells, Instruments, Services) by Application (Therapeutic, Industrial, Research) by End-user (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End-users) and by Geography.
The Europe protein expression market is expected to progress at a CAGR of 10.57% during the forecast period, 2019-2028. The utilization of protein expression for various disease therapies has increased. The region has a high prevalence rate of cancer, with a substantial number of cases getting registered every year. The most prevalent cancers are female breast cancer followed by prostate cancer, lung cancer, and colorectal cancer. Along with these, the presence of key players contributes to boosting the overall growth of the market. Moreover, many countries of the European region like Switzerland, France, Germany, and the United Kingdom, boast of developed healthcare infrastructure, and there is a high focus on genomics and proteomics research activities.
To learn more about this report, request a free sample copy
The countries assessed in the Europe protein expression market growth evaluation are Russia, Germany, the United Kingdom, Italy, France, Poland, Belgium, and the rest of Europe. The UK is considered to be a major country in terms of R&D, and there is high adoption of new technology in healthcare in comparison to other European countries. There has also been an increase in investment for the same. The market growth is further supplemented by several technological advancements, adequate funding support, and efficient industry structure. Academic research on protein in several universities is a major revenue generation source in the UK. The application in the pharmaceutical and biotechnology industries will be contributing significantly to market growth in the years to come. Many companies in the region, like Thermofischer Scientific, Amsbio, Eurogentec, etc. are increasing their research on protein in the biotechnology sector, all of which considerably increases the demand for protein expression in the country.
Qiagen NV supplies samples to insight solutions that majorly transform biological materials into molecular insights. It provides sample technologies for ribonucleic acid purification, plasmid deoxyribonucleic acid purification, genomic and viral nucleic acid purification, etc. The product portfolio of the company includes, Bacteria Protein Expression, E. Coli Expression System, Baculovirusinfected cells Expression System, Other Protein Expression products, etc. The company has its headquarters in Hilden, Germany.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- MARKET DEFINITION
- Â Â KEY DRIVERS
- INCREASING NUMBER OF CHRONIC DISEASE
- WORLDWIDE RISE IN HEALTHCARE EXPENDITURE
- INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS
- Â Â KEY RESTRAINTS
- HIGH COST OF PROTEIN EXPRESSION SYSTEMS
- LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS
- KEY ANALYTICS
- KEY INVESTMENT INSIGHTS
-   PORTER’S FIVE FORCE ANALYSIS
- BUYER POWER
- SUPPLIER POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY PRODUCT TYPE
- REAGENTS
- EXPRESSION VECTORS
- COMPETENT CELLS
- INSTRUMENTS
- SERVICES
- MARKET BY APPLICATION
- THERAPEUTIC
- INDUSTRIAL
- RESEARCH
- MARKET BY END-USER
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- ACADEMIC RESEARCH INSTITUTES
- CONTRACT RESEARCH ORGANIZATIONS
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- Â Â EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- Â Â EUROPE
- COMPANY PROFILES
- AGILENT TECHNOLOGIES INC
- BECTON, DICKINSON AND COMPANY
- BIO-RAD LABORATORIES INC
- GENSCRIPT BIOTECH CORPORATION
- LIFESENSORS INC
- MERCK KGAA
- PROMEGA CORPORATION
- QIAGEN N.V.
- TAKARA HOLDINGS INC
- THERMO FISHER SCIENTIFIC INC
- LONZA INC
- NEW ENGLAND BIOLABS
- BIOTECHRABBIT GMBH
- PROMAB BIOTECHNOLOGIES GMBH
- PEAK PROTEINS LTD
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PROTEIN EXPRESSION
TABLE 2: EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE PROTEIN EXPRESSION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: EUROPE PROTEIN EXPRESSION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: KEY INVESTMENT INSIGHTS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: EUROPE PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2019
FIGURE 6: EUROPE PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 7: EUROPE PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)
FIGURE 11: EUROPE PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
FIGURE 12: EUROPE PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)
FIGURE 15: EUROPE PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
FIGURE 16: EUROPE PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)
FIGURE 17: EUROPE PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
FIGURE 18: EUROPE PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)
FIGURE 19: EUROPE PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 20: EUROPE PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 21: UNITED KINGDOM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 22: GERMANY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: FRANCE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: ITALY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 25: RUSSIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 26: BELGIUM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 27: POLAND PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 28: REST OF EUROPE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- Â Â EUROPE
- UNITED KINGDOM
- GERMANY
- FRANCE
- ITALY
- RUSSIA
- BELGIUM
- POLAND
- REST OF EUROPE
- Â Â EUROPE
- MARKET BY PRODUCT TYPE
- REAGENTS
- EXPRESSION VECTORS
- COMPETENT CELLS
- INSTRUMENTS
- SERVICES
- MARKET BY APPLICATION
- THERAPEUTIC
- INDUSTRIAL
- RESEARCH
- MARKET BY END-USER
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- ACADEMIC RESEARCH INSTITUTES
- CONTRACT RESEARCH ORGANIZATIONS
- OTHER END-USERS
Â
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.